Скачать или смотреть Delphi Insight Session PMA Fundraiser

This Delphi Insight Session provides an in-depth look at the Psychedelic Medicine Association (PMA) and its role in advancing psychedelic healthcare. The session, hosted by Delphi, a consulting firm focused on psychedelic healthcare, features Lia Mix, Delphi's CEO, and Dr. Lynn Marie Morski, founder and president of PMA.

Key points covered:
▶ Overview of challenges in integrating psychedelic therapies into mainstream healthcare
▶ Importance of organizations like PMA in interfacing with the medical community and healthcare systems
▶ PMA's mission to educate healthcare professionals on psychedelic therapeutics
▶ PMA's membership base, including 1200 clinicians and 80+ organizations
▶ PMA's educational initiatives, including continuing education courses, webinars, and research bulletins
▶ PMA's plans to develop accreditation programs for psychedelic therapy training
▶ PMA's role in creating clinical practice guidelines for psychedelic therapies
▶ PMA's achievements, including collaborations with Psych Congress and Medscape
▶ The complex process of developing clinical practice guidelines and accreditation programs

Dr. Morski emphasizes PMA's unique position to steward the creation of infrastructure necessary for the effective implementation of psychedelic medicine. She highlights the organization's efforts to bridge the gap between clinical research and frontline healthcare and its dedication to building trust within the medical community.

The insight session underscores the critical timing of PMA's work, especially in light of recent challenges in FDA approval processes for psychedelic therapies. It emphasizes the need for rigorous certification, oversight, and standardization in the field of psychedelic medicine. Finally, it highlights PMA as a critical player in the professionalization and mainstream integration of psychedelic therapies, working to ensure safe, effective, and accessible treatment options for patients in need.